TCL Archive Patient Advocacy: Policy Should Prevent Employers From Using Genetic Test Results April 11, 1997
TCL Archive After Aggressive Budgetary Trimming, At $33 Million NCI’s caBIG Remains Big December 2, 2011
TCL Archive Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival April 25, 2014
TCL Archive Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds May 27, 2005
TCL Archive In Brief: In Vitro Systems Will Be 90% Reliable, Ames Says; GAO Asks For Reassessment of Saccharin October 1, 1976
